Name | 4-[2-(3,4-dimethoxyphenyl)ethyl]-2,6-dimethoxyphenol |
---|---|
Synonyms | Phenol,4-[2-(3,4-dimethoxyphenyl)ethyl]-2,6-dimethoxy |
Description | Chrysotoxine is a dual inhibitor of Src/Akt. Chrysotoxine suppresses cancer stem cells (CSCs) phenotypes by down-regulating Src/Akt signaling. Chrysotoxine reduces cell viability and increases apoptosis level in H460 and H23 cells instead of non-tumor cell lines. Chrysotoxine shows rapid excretion and low bioavailability in rats. Chrysotoxine is used in cancer research[1][2]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C18H22O5 |
---|---|
Molecular Weight | 318.36 |
Exact Mass | 318.14700 |
PSA | 57.15000 |
LogP | 3.21180 |
Storage condition | -20°C |